[PDF][PDF] Multiple sclerosis update

CE Markowitz - Am J Manag Care, 2013 - ajmc.s3.amazonaws.com
Multiple sclerosis (MS) is a chronic but incurable disease of the central nervous system
(CNS) that is often diagnosed in the second or third decade of life. It is more common among …

Clinical presentation, course, and prognosis of multiple sclerosis in adults

M Olek, J Howard - UptoDate, 2018 - uptodate.com
Multiple sclerosis (MS) is the most common immune-mediated inflammatory demyelinating
disease of the central nervous system. The onset and phenotypes of MS will be reviewed …

Multiple sclerosis: it's not the disease you thought it was

LA Rolak - Clinical Medicine & Research, 2003 - Marshfield Clinic
Multiple sclerosis (MS), the most common disabling neurologic disease of young people,
afflicts approximately a quarter of a million Americans. The symptoms of MS result from …

[图书][B] Multiple sclerosis: Clinician's guide to diagnosis and treatment

GL Birnbaum - 2013 - books.google.com
Multiple Sclerosis (MS) is an inflammatory, often progressive, and potentially disabling
disease of the central nervous system. Onset of disease is usually between the ages of 15 …

Multiple sclerosis re-examined: essential and emerging clinical concepts

J Zurawski, J Stankiewicz - The American journal of medicine, 2018 - Elsevier
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system
characterized by exacerbations of neurological dysfunction due to inflammatory …

[PDF][PDF] Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis

MJ Tullman - Am J Manag Care, 2013 - ajmc.s3.amazonaws.com
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central
nervous system that affects approximately 400,000 people in the United States. The etiology …

Multiple sclerosis: an immune or neurodegenerative disorder?

BD Trapp, KA Nave - Annu. Rev. Neurosci., 2008 - annualreviews.org
Multiple sclerosis (MS) is an inflammatory-mediated demyelinating disease of the human
central nervous system. The clinical disease course is variable, usually starts with reversible …

What is multiple sclerosis?

R Marcus - Jama, 2022 - jamanetwork.com
Who Is Affected by and at Risk of MS? About 900 000 people in the US have MS. Onset of
symptoms typically occurs at age 20 to 30 years. Women are nearly 3 times more likely to …

Management of multiple sclerosis symptoms and comorbidities

WO Tobin - CONTINUUM: Lifelong Learning in Neurology, 2019 - journals.lww.com
Management of Multiple Sclerosis Symptoms and Comorbidities : CONTINUUM: Lifelong
Learning in Neurology Account Register Activate Subscription Help Subscribe American …

[HTML][HTML] An overview of the history, pathophysiology, and pharmacological interventions of multiple sclerosis

IM Dighriri, AA Aldalbahi, F Albeladi, AA Tahiri… - Cureus, 2023 - ncbi.nlm.nih.gov
Multiple sclerosis (MS) is an immune-inflammatory disease that attacks and damages
myelinated axons in the central nervous system (CNS) and causes nontraumatic …